Embedded Files
B12 shot PROMO Happening NOW!
Medical Weight Loss
Medical Weight Loss
Kickstart your weight loss journey with Karmi Wellness! Gain access to compounded tirzepatide and semaglutide during the shortage. Weight loss injections are a great option for those with a BMI > 30 or BMI ≥ 27 with weight-related comorbidities, and ideal for managing insulin resistance related to PCOS. Low Dose Naltrexone (LDN) is also a useful complementary therapy to use along side medical weight loss and lifestyle changes.
** The Food and Drug Administration (FDA) has removed semaglutide and tirzepatide from its drug shortage list, meaning that the manufacturer can meet current and projected national demand. Therefore, compounding pharmacies are no longer able to distribute either medication. Liraglutide is still an option, as well as LillyDirect® (Zepbound/tirzepatide) and NovoCare® (Wegovy/semaglutide). We will work with you to ensure your weight loss journey and goals are supported!
Semaglutide
Semaglutide
Semaglutide, a potent glucagon-like peptide-1 (GLP-1) receptor agonist initially prescribed for Type 2 Diabetes, now stands as a groundbreaking treatment addressing obesity. Administered weekly via injections, it not only effectively regulates blood sugar levels, but also induces significant weight loss.
Click the icon to learn more.
Tirzepatide
Tirzepatide
Tirzepatide, a cutting-edge dual GIP (glucose-dependent insulinotropic peptide) and GLP-1 (glucagon-like peptide-1) receptor agonist, signifies a transformative breakthrough in obesity treatment. Administered weekly through injections, it not only effectively manages blood sugar levels, but also stands out for its remarkable weight loss benefits. As the next-generation GLP-1, Tirzepatide represents an innovative approach at the forefront of metabolic health solutions.
Click the icon to learn more.
Low Dose Naltrexone
Low Dose Naltrexone
Low dose naltrexone (LDN) is gaining attention for its use in weight loss due to its ability to modulate the immune system and reduce inflammation. By blocking opioid receptors temporarily, LDN is thought to reset the body’s endorphin production, which can help regulate appetite and cravings.
Google Sites
Report abuse